Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Lepr
Document Type
Article
Publication Date
4-1-2018
Institution/Department
Center for Molecular Medicine; Maine Medical Center Research Institute
Journal Title
Annals of the New York Academy of Sciences
MeSH Headings
Animals, Blood Glucose, Body Composition, Body Weight, Cardiomyopathies, Cardiotonic Agents, Diabetes Mellitus, Type 2, Diet, Disease Models, Animal, Echocardiography, Female, Insulin, Insulin Resistance, Longevity, Male, Mice, Mice, Inbred C57BL, Sirolimus, Weight Gain
Abstract
Rapamycin (RAPA), an inhibitor of mTORC signaling, has been shown to extend life span in mice and other organisms. Recently, animal and human studies have suggested that inhibition of mTORC signaling can alleviate or prevent the development of cardiomyopathy. In view of this, we used a murine model of type 2 diabetes (T2D), BKS-Lepr
ISSN
1749-6632
First Page
106
Last Page
117
Recommended Citation
Reifsnyder, Peter C; Ryzhov, Sergey; Flurkey, Kevin; Anunciado-Koza, Rea P; Mills, Ian; Harrison, David E; and Koza, Robert A, "Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Lepr" (2018). MaineHealth Maine Medical Center. 1448.
https://knowledgeconnection.mainehealth.org/mmc/1448